You are required to be logged in to access the full website
User Name: Password:
Click here if you have forgotten your username or password
  • Home
  • Latest News
  • Search
  • About M2 Pharma
  • Subscribe
Business & Finance
Generics
Therapy Areas
Policy & Regulation
Research & Development
People
People
Novartis cancels plan to shut down Swiss facility
17 January 2012 - Swiss Novartis (VTX:NOVN) dropped its plans to shut down its site in Swiss Nyon, Pascal Brenneisen, head of the company's Swiss operations, told media on Tuesday.

Novartis unveiled in October 2011 it will axe 2,000 jobs worldwide seeking annual savings of approximatel...

 

 

 

You must be logged in to view the whole article.
Click here if you require signing up

 

 

 

Login
Username:

Password:


Related Headlines

GlaxoSmithKline says several board members will not stand for re-election

LoneStar Heart appoints Names Andrew Coats, Mark Maciejewski to board of directors

Gerald Storch joins Bristol-Myers Squibb's board of directors

Cleveland BioLabs shakes up management

Claude Allary to serve as special advisor to Arch Biopartners

Blueprint Medicines hires Christoph Lengauer as chief scientific officer

Covidien names head of Vascular Therapies business

Zeltia's Noscira to slash jobs

Astellas Pharma Europe promotes Mike Crooks to general manager of UK unit

Two directors step down from Sirona board

Takeda to shed 2,800 jobs in Europe, US

Novartis cancels plan to shut down Swiss facility

Array BioPharma announces CEO's departure

PuraMed BioScience names Sue Baacke CFO

Lombard Medical names Ian Ardill CFO

Designed by Create Marketing
Home | Business & Finance | Generics | Therapy Areas | Policy & Regulation | Research & Development | People | Search | About M2 Pharma | Subscribe
Copyright © 2013